This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Circulation: CardiovascularImaging, Volume 16, Issue 11 , Page e000081, November 1, 2023. Infiltrative cardiomyopathies comprise a broad spectrum of inherited or acquired conditions caused by deposition of abnormal substances within the myocardium. thereby eliminating the need for endomyocardial biopsy in most cases.
Circulation: CardiovascularImaging, Ahead of Print. It is well understood that cancer therapies including chemotherapy, tyrosine kinase inhibitors, immune checkpoint inhibitors, and radiation can increase the risk of cardiovascular disease in patients with cancer.
Enlargement of the left ventricular cavity, increased wall thickness and increased trabeculations in athlete’s heart will have to be differentiated from conditions like dilated cardiomyopathy, hypertrophic cardiomyopathy and isolated left ventricular non-compaction. Differentiating Athlete’s Heart From Cardiomyopathies – The Left Side.
Integration and Advancements In the second stage, spanning the 1980s to 2010, significant progress was made in using magnetic resonance technology to capture various cardiovascularimages. This comprehensive approach allows for precise differentiation between various cardiomyopathies, myocarditis, and myocardial infarction.
American Society of Echocardiography clinical recommendations for multimodality cardiovascularimaging of patients with pericardial disease: endorsed by the Society for Cardiovascular Magnetic Resonance and Society of Cardiovascular Computed Tomography. J Am Soc Echocardiogr. 2013 Sep;26(9):965-1012.e15. 2013.06.023.
Anuradha Lala-Trindade, MD: She focuses on the selection and care of patients with mechanical circulatory support devices and heart transplantation, genetic cardiomyopathies, and perioperative management of high-risk cardiac surgical cases. Brittany Weber MD, Ph.D.:
We organize all of the trending information in your field so you don't have to. Join thousands of users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
40 
Let's personalize your content